1. Home
  2. AVIR vs NXG Comparison

AVIR vs NXG Comparison

Compare AVIR & NXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$5.21

Market Cap

429.1M

Sector

Health Care

ML Signal

HOLD

Logo NXG NextGen Infrastructure Income Fund of Beneficial Interest

NXG

NXG NextGen Infrastructure Income Fund of Beneficial Interest

HOLD

Current Price

$54.34

Market Cap

412.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVIR
NXG
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
429.1M
412.0M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
AVIR
NXG
Price
$5.21
$54.34
Analyst Decision
Buy
Analyst Count
1
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 239.9K
61.7K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
★ 14.78%
EPS Growth
★ 3.00
N/A
EPS
N/A
★ N/A
Revenue
★ $351,367,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$47.10
52 Week High
$6.45
$65.78

Technical Indicators

Market Signals
Indicator
AVIR
NXG
Relative Strength Index (RSI) 47.16 40.78
Support Level $5.09 $54.03
Resistance Level $5.79 $55.26
Average True Range (ATR) 0.23 1.05
MACD -0.04 0.08
Stochastic Oscillator 23.53 18.42

Price Performance

Historical Comparison
AVIR
NXG

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

About NXG NXG NextGen Infrastructure Income Fund of Beneficial Interest

Cushing NextGen Infrastructure Income Fund is a closed-end management investment company. Its investment objective is to seek a high total return with an emphasis on current income. The fund invests at least 80% of its net assets in a portfolio of equity and debt securities of infrastructure companies, including energy infrastructure companies, industrial infrastructure companies, sustainable infrastructure companies and technology and communication infrastructure companies.

Share on Social Networks: